Cisplatin Neurotoxicity in Testis Cancer Treatment
Author Information
Author(s): Schlippe M von, Fowler C J, Harland S J
Primary Institution: University College, London
Hypothesis
What is the incidence and prognosis of cisplatin-induced neurotoxicity in testis cancer patients undergoing combination chemotherapy?
Conclusion
Most patients experienced resolution of neurotoxicity symptoms within 12 months after chemotherapy, despite a significant initial deterioration in vibration thresholds during treatment.
Supporting Evidence
- At the end of chemotherapy, only 11% of patients had nerve symptoms.
- Three months after chemotherapy, 65% of patients reported symptoms.
- 17% of patients had persistent symptoms after 12 months.
Takeaway
Doctors studied 29 cancer patients to see how cisplatin affects their nerves. Most felt better after a year, even though they had some nerve problems during treatment.
Methodology
29 patients with metastatic disease were studied prospectively, assessing neurological symptoms and measuring nerve function.
Participant Demographics
Patients with metastatic germ cell tumors undergoing chemotherapy.
Statistical Information
P-Value
P = 0.032, P = 0.009, P = 0.038
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website